Fall 2007 Speaker Series: Innovation in Health Care
September 5, 2007
Robert I. Field Read More
Chair, Dept. of Health Policy & Public Health
Professor of Health Policy
"American Health Care Regulation as an Assortment of Public-Private Partnerships"
September 12, 2007
Harold Glass, PhD
Research Professor of Health Policy, USP
"The Role of Innovation in a Physician's Decision to Take Part in Clinical Trials"
September 19, 2007
Lawrence Poli, PhD
President, Center for Performance Excellence
"The Challenges of Medical Innovation"
September 26, 2007
Ira Spector, MD
Vice President, Research & Development, Wyeth Pharmaceuticals
"Metrics and New Drug Development"
Monday, October 1, 2007
3 p.m. - 4:20 p.m. in Wilson 205
Naoki Ikegami, MD, MA
Professor of Health Policy and Man.
Keio University, Tokyo Japan
"Overview of the Japanese Health Care System"
October 3, 2007
Bruce Lamont
CEO, Graphwise LLC
"Innovation in Medicine: Bringing a New Concept to Fruition"
October 10, 2007
James Laughlin
Vice President, TTC
"Direct-to-Consumer Advertising and New Drug Adoption"
October 17, 2007
M. DeFelice
Vice President, Merck/J&J Joint Venture
"Over-the-Counter Drugs: New Approaches to Innovation"
October 24, 2007
John Clark, MD
Vice President, Risk Metrics
"Drug Safety and Medical Innovation"
Spring 2007 Speaker Series: Issues in Drug Safety
Jan. 24: Robert I. Field, J.D., M.P.H., Ph.D. Read More
Associate Professor of Health Policy
“Post-market drug safety regulation”
Research Professor of Health Policy
“Pharmaceutical clinical trials”
Feb. 7:Richard G. Stefanacci, D.O., M.G.H. Read More
Associate Professor of Health Policy
“Geriatric drug safety concerns”
Feb. 21:David Snyder, Ph.D.
ECRI
“Drug evaluations and review process”
Adjunct Associate Professor, USP
Assistant Director, R&D Management Operations
Centocor R&D Inc.
“Safety assessment in clinical trials”
March 21: Symposium – The Future of Drug Safety Read More
4:30 p.m. – 6:30 p.m., STC 145
March 28:Mark Vermette
President, CrossPhase Consulting
“Drug safety databases and the FDA”
Omnicare
“Long-term care pharmacy drug surveillance”
Vice President, UBC
“Post marketing safety surveillance”
Fall 2006 Speaker Series
September 6: Richard G. Stefanacci, D.O., M.G.H., M.B.A. Read More
Founding Executive Director, USP Health Policy Institute; Associate Professor of Health Policy
"Geriatric Policy and Medicine"
September 13: Harold Glass, Ph.D. Read More
Professor of Health Policy
"Pharmaceutical Clinical Trials"
September 20: Robert I. Field, J.D., M.P.H., Ph.D.
Director, Health Policy Program; Associate Professor of Health Policy
"Post-Market Drug Safety Surveillance"
September 27: David Nash, M.D., M.B.A. Read More
See his presentation here
Chair, Department of Health Policy at Thomas Jefferson University
"Quality Measurement"
October 4: Albert Wertheimer, Ph.D. Read More
Professor, Temple University
"Pharmaceutical Policy and Outcomes Research"
October 11: Lynn Oppenheim, Ph.D. Read More
President and CEO, Center for Applied Research
Barton Parrott, M.B.A.
Senior Manager, Center for Applied Research
"The Future of Health Care"
October 18: Stephen Metraux, Ph.D. Read More
Assistant Professor of Health Policy
"Mental Health and Community Reentry from Prison"
October 25: Karen Schoelles, M.D., SM Read More
Medical Director, Evidence-Based Practice Center, ECRI
"Health Care Technology Assessment"
November 1: Vivian Valdmanis Read More
Associate Professor of Health Policy
"Health Care in Developing Countries"
November 15: Student Presentation Read More
"Health Disparities"
Spring 2006 Series Long Term Health Care: The Problems
February 1: Wayne Pendleton Read More
CEO, LIFE/Penn School of Nursing
Home & Community-Based Long Term Care Options
February 8: Larry Lane Read More
VP, Government Relations; Genesis Healthcare
Current and Future Issues Faced by the Nursing Home Industry
February 15: Neil I. Goldfarb Read More
Director of Research,Dept. of Medical Policy, Jefferson Medical College
Measuring Quality in Long Term Care
March 15: Jim Pezzuti Read More
Director, Division of LTC Clint Services, Dept. of Public Welfare Office of Medical Assistance
Direction and Trends in LTC from Payers PerspectiveMarch 22: J.P. Geronimi Read More
Sr. Manager, Senior Care Marketing, Sanofi-Aventis
The Pharmaceutical Industry's View of Long Term Care
To Read More About our Past Series in the Medicare Drug Benefit
Click on the "Read More" links below:
September 14: Paul Baldwin READ MORE
Executive Director, Long Term Care Pharmacy Alliance
The Impact of Medicare Part D on Long Term Care
September 21: Daniel C. Lyons, MD READ MORE
Senior Vice President, Government Programs, Independence Blue Cross
How a Large Health Plan is Adapting to Medicare Part D
October 12: Mark H. Beers, MD READ MORE
Editor in Chief, The Merck Manuals; Executive Director, Geriatrics and Clinical Literature Merck & Co., Inc.
How will the Beers Criteria Work under Medicare Part D?
|